These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 27836822

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Patient adherence to generic versus brand statin therapy after acute myocardial infarction: Insights from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the American College of Cardiology/American Heart Association Guidelines Registry.
    O'Brien EC, McCoy LA, Thomas L, Peterson ED, Wang TY.
    Am Heart J; 2015 Jul; 170(1):55-61. PubMed ID: 26093864
    [Abstract] [Full Text] [Related]

  • 6. Impact of medicare part D plan features on use of generic drugs.
    Tang Y, Gellad WF, Men A, Donohue JM.
    Med Care; 2014 Jun; 52(6):541-8. PubMed ID: 24824538
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of the Medicare Part D coverage gap on medication use among patients with hypertension and hyperlipidemia.
    Li P, McElligott S, Bergquist H, Schwartz JS, Doshi JA.
    Ann Intern Med; 2012 Jun 05; 156(11):776-84, W-263, W-264, W-265, W-266, W-267, W-268, W-269. PubMed ID: 22665815
    [Abstract] [Full Text] [Related]

  • 9. The impact of manufacturer coupon use in the statin market.
    Daugherty JB, Maciejewski ML, Farley JF.
    J Manag Care Pharm; 2013 Jun 05; 19(9):765-72. PubMed ID: 24156645
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparative effectiveness of generic and brand-name statins on patient outcomes: a cohort study.
    Gagne JJ, Choudhry NK, Kesselheim AS, Polinski JM, Hutchins D, Matlin OS, Brennan TA, Avorn J, Shrank WH.
    Ann Intern Med; 2014 Sep 16; 161(6):400-7. PubMed ID: 25222387
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Comparison of compliance and cost effectiveness between brand-name statins and generic statins].
    He L, Du X, Wang WH, Ma CS.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Nov 10; 41(11):1900-1904. PubMed ID: 33297658
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of Generic Competition on Atorvastatin Prescribing and Patients' Out-of-Pocket Spending.
    Luo J, Seeger JD, Donneyong M, Gagne JJ, Avorn J, Kesselheim AS.
    JAMA Intern Med; 2016 Sep 01; 176(9):1317-23. PubMed ID: 27367749
    [Abstract] [Full Text] [Related]

  • 16. The effect of the US Medicare Part D coverage gaps on medication use among patients with depression and heart failure.
    Baik SH, Rollman BL, Reynolds CF, Lave JR, Smith KJ, Zhang Y.
    J Ment Health Policy Econ; 2012 Sep 01; 15(3):105-18. PubMed ID: 23001279
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Adherence and persistence to prescribed medication therapy among Medicare part D beneficiaries on dialysis: comparisons of benefit type and benefit phase.
    Park H, Rascati KL, Lawson KA, Barner JC, Richards KM, Malone DC.
    J Manag Care Spec Pharm; 2014 Aug 01; 20(8):862-76. PubMed ID: 25062080
    [Abstract] [Full Text] [Related]

  • 19. Comparison of statin adherence among beneficiaries in MA-PD plans versus PDPs.
    Jung K, McBean AM, Kim JA.
    J Manag Care Pharm; 2012 Mar 01; 18(2):106-15. PubMed ID: 22380470
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.